Table 1.

Relationship of the presence or absence of CD19+ cells coexpressing CD10 and/or CD34 on day 19 with presenting clinicobiologic features of children with ALL




CD19+ cells coexpressing CD10 and/or CD34 on day 19

Presenting feature
Patients studied
Absent
Present
P*
Age, y     .962  
Younger than 1   6   3   3   
1 to 9   288   128   160   
10 or older   86   38   48   
Race     .916  
White   301   135   166   
Black   48   20   28   
Other   31   14   17   
Sex     .164  
Male   204   84   120   
Female   176   85   91   
WBC, × 109/L     .246  
Less than 50   300   138   162   
50 or more   80   31   49   
BCR-ABL     .001  
Absent   366   169   197   
Present   13   0   13   
TEL-AML 1     < .001  
Absent   273   110   163   
Present   83   51   32   
MLL-AF4     .834  
Absent   373   167   206   
Present   4   2   2   
DNA index     .083  
1.16 or more   111   57   54   
Other   269   112   157   
NCI risk     .791  
Standard   227   102   125   
High   147   64   83   
Not applicable
 
6
 
3
 
3
 

 



CD19+ cells coexpressing CD10 and/or CD34 on day 19

Presenting feature
Patients studied
Absent
Present
P*
Age, y     .962  
Younger than 1   6   3   3   
1 to 9   288   128   160   
10 or older   86   38   48   
Race     .916  
White   301   135   166   
Black   48   20   28   
Other   31   14   17   
Sex     .164  
Male   204   84   120   
Female   176   85   91   
WBC, × 109/L     .246  
Less than 50   300   138   162   
50 or more   80   31   49   
BCR-ABL     .001  
Absent   366   169   197   
Present   13   0   13   
TEL-AML 1     < .001  
Absent   273   110   163   
Present   83   51   32   
MLL-AF4     .834  
Absent   373   167   206   
Present   4   2   2   
DNA index     .083  
1.16 or more   111   57   54   
Other   269   112   157   
NCI risk     .791  
Standard   227   102   125   
High   147   64   83   
Not applicable
 
6
 
3
 
3
 

 
*

Calculated by Pearson chi-square test.

Data not available for all patients.

or Create an Account

Close Modal
Close Modal